Francesc Bosch
Francesc Bosch
Head, Department of Hematology, Professor of Hematology at University Hospital Vall d'Hebron
Verified email at
Cited by
Cited by
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
JMM Walboomers, MV Jacobs, MM Manos, FX Bosch, JA Kummer, ...
The Journal of pathology 189 (1), 12-19, 1999
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz, FX Bosch, S De Sanjosé, R Herrero, X Castellsagué, KV Shah, ...
New England journal of medicine 348 (6), 518-527, 2003
The causal relation between human papillomavirus and cervical cancer
FX Bosch, A Lorincz, N Muñoz, C Meijer, KV Shah
Journal of clinical pathology 55 (4), 244-265, 2002
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective
FX Bosch, MM Manos, N Muñoz, M Sherman, AM Jansen, J Peto, ...
JNCI: Journal of the National Cancer Institute 87 (11), 796-802, 1995
Primary liver cancer: worldwide incidence and trends
FX Bosch, J Ribes, M Díaz, R Cléries
Gastroenterology 127 (5), S5-S16, 2004
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
S de Sanjose, WGV Quint, L Alemany, DT Geraets, JE Klaustermeier, ...
The lancet oncology 11 (11), 1048-1056, 2010
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a …
J Paavonen, P Naud, J Salmerón, CM Wheeler, SN Chow, D Apter, ...
The Lancet 374 (9686), 301-314, 2009
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
S De Sanjosé, M Diaz, X Castellsagué, G Clifford, L Bruni, N Muñoz, ...
The Lancet infectious diseases 7 (7), 453-459, 2007
ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia
M Crespo, F Bosch, N Villamor, B Bellosillo, D Colomer, M Rozman, ...
New England Journal of Medicine 348 (18), 1764-1775, 2003
Against which human papillomavirus types shall we vaccinate and screen? The international perspective
N Munoz, FX Bosch, X Castellsagué, M Díaz, S De Sanjose, ...
International journal of cancer 111 (2), 278-285, 2004
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of …
J Paavonen, D Jenkins, FX Bosch, P Naud, J Salmerón, CM Wheeler, ...
The Lancet 369 (9580), 2161-2170, 2007
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study
R Herrero, X Castellsagué, M Pawlita, J Lissowska, F Kee, P Balaram, ...
Journal of the National Cancer Institute 95 (23), 1772-1783, 2003
Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings
L Bruni, M Diaz, M Castellsagué, E Ferrer, FX Bosch, S de Sanjosé
Journal of Infectious Diseases 202 (12), 1789-1799, 2010
Chapter 1: Human papillomavirus and cervical cancer—burden and assessment of causality
FX Bosch, S De Sanjosé
JNCI monographs 2003 (31), 3-13, 2003
Epidemiology of primary liver cancer
FX Bosch, J Ribes, J Borràs
Seminars in liver disease 19 (03), 271-285, 1999
Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners
X Castellsagué, FX Bosch, N Munoz, CJLM Meijer, KV Shah, ...
New England journal of medicine 346 (15), 1105-1112, 2002
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia
FX Bosch, AN Burchell, M Schiffman, AR Giuliano, S de Sanjose, L Bruni, ...
Vaccine 26, K1-K16, 2008
Epidemiology of hepatocellular carcinoma
FX Bosch, J Ribes, R Cléries, M Díaz
Clinics in liver disease 9 (2), 191-211, 2005
Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study
V Moreno, FX Bosch, N Muñoz, CJLM Meijer, KV Shah, JMM Walboomers, ...
The Lancet 359 (9312), 1085-1092, 2002
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
A Rosenwald, G Wright, A Wiestner, WC Chan, JM Connors, E Campo, ...
Cancer cell 3 (2), 185-197, 2003
The system can't perform the operation now. Try again later.
Articles 1–20